Multi-Center Study: The Biochemical Efficacy, Safety and Tolerability of a New  1 -Proteinase Inhibitor, Zemaira

Author: Stocks James   Brantly Mark   Pollock David   Barker Alan   Kueppers Friedrich   Strange Charlie   Donohue James   Sandhaus Robert  

Publisher: Informa Healthcare

ISSN: 1541-2555

Source: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol.3, Iss.1, 2006-05, pp. : 17-23

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content